Marc A. Pfeffer

Sep 1, 2024 | onlinelibrary.wiley.com | Henri Lu |Brian Claggett |Milton Packer |Marc A. Pfeffer

Supporting Information Filename Description ejhf3414-sup-0001-Supinfo.docxWord 2007 document , 6.5 MB Appendix S1. Supporting Information. References 1, . Anemia and iron deficiency in heart failure: Current concepts and emerging therapies. Circulation 2018; 138: 80–98. https://doi.org/10.1161/CIRCULATIONAHA.118.030099 2, , , , , , et al.; CHARM Committees and Investigators.

Aug 30, 2024 | jamanetwork.com | Samantha Anderer |James Curtain |Marc A. Pfeffer |Eugene Braunwald

Contemporary Post-MI Treatments Reduce Risk of Sudden Death Rates of Sudden Death After Myocardial Infarction—VALIANT and PARADISE-MI Trials James P. Curtain, MB, BS; Marc A. Pfeffer, PhD; Eugene Braunwald, MD; Brian L. Claggett, PhD; Christopher B. Granger, MD; Lars Køber, MD, DSci; Eldrin F. Lewis, MD, MPH; Aldo P. Maggioni, MD; Doug L. Mann, MD; Jean L. Rouleau, MD; Scott D. Solomon, MD; Philippe Gabriel Steg, MD; Peter V. Finn, MD; Alberto Fernandez, MD; Karola S.

Aug 8, 2024 | jamanetwork.com | James Curtain |Marc A. Pfeffer |Brian Claggett |Christopher B Granger

Key PointsQuestion  Has the sudden death rate after myocardial infarction and the characteristics of people dying suddenly changed over time?

May 29, 2024 | jamanetwork.com | Li Shen |Hangzhou Normal |Christopher B Granger |Marc A. Pfeffer

Key PointsQuestion  Does the benefit of renin-angiotensin system (RAS) blockers in patients with heart failure and reduced ejection fraction differ between Black and non-Black patients? Findings  In this meta-analysis involving more than 16 000 patients from 5 randomized trials, the mortality benefit from RAS blockade was similar in Black and non-Black patients.